Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease

BACKGROUND: Sickle cell disease is the most common monogenic hereditary disease in Brazil. Although strokes are one of the main causes of morbidity and mortality in these patients, the use of transcranial Doppler to identify children at risk is not universally used. OBJECTIVE: To develop Brazilian guidelines for the use of transcranial Doppler in sickle cell disease children and adolescents, so that related health policies can be expanded, and thus contribute to reduce morbidity and mortality. METHODS: The guidelines were formulated in a consensus meeting of experts in transcranial Doppler and sickle cell disease. The issues discussed were previously formulated and scientific articles in databases (MEDLINE, SciELO and Cochrane) were carefully analyzed. The consensus for each question was obtained by a vote of experts on the specific theme. RESULTS: Recommendations were made, including indications for the use of transcranial Doppler according to the sickle cell disease genotype and patients age; the necessary conditions to perform the exam and its periodicity depending on exam results; the criteria for the indication of blood transfusions and iron chelation therapy; the indication of hydroxyurea; and the therapeutic approach in cases of conditional transcranial Doppler. CONCLUSION: The Brazilian guidelines on the use of transcranial doppler in sickle cell disease patients may reduce the risk of strokes, and thus reduce the morbidity and mortality and improve the quality of life of sickle cell disease patients.

Saved in:
Bibliographic Details
Main Authors: Lobo,Clarisse Lopes de Castro, Cançado,Rodolfo Delfini, Leite,Ana Claudia Celestino Bezerra, Anjos,Ana Claudia Mendonça dos, Pinto,Ana Cristina Silva, Matta,Andre Palma da Cunha, Silva,Célia Maria, Silva,Gisele Sampaio, Friedrisch,João Ricardo, Braga,Josefina Aparecida Pellegrini, Lange,Marcos Christiano, Figueiredo,Maria Stella, Rugani,Marília Álvares, Veloso,Orlando, Moura,Patrícia Gomes, Cortez,Paulo Ivo, Adams,Robert, Gualandro,Sandra Fátima Menosi, Castilho,Shirley Lopes de, Thomé,Ursula, Zetola,Viviane Flumignan
Format: Digital revista
Language:English
Published: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular 2011
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000100014
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-84842011000100014
record_format ojs
spelling oai:scielo:S1516-848420110001000142011-05-05Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell diseaseLobo,Clarisse Lopes de CastroCançado,Rodolfo DelfiniLeite,Ana Claudia Celestino BezerraAnjos,Ana Claudia Mendonça dosPinto,Ana Cristina SilvaMatta,Andre Palma da CunhaSilva,Célia MariaSilva,Gisele SampaioFriedrisch,João RicardoBraga,Josefina Aparecida PellegriniLange,Marcos ChristianoFigueiredo,Maria StellaRugani,Marília ÁlvaresVeloso,OrlandoMoura,Patrícia GomesCortez,Paulo IvoAdams,RobertGualandro,Sandra Fátima MenosiCastilho,Shirley Lopes deThomé,UrsulaZetola,Viviane Flumignan Ultrasonography, doppler, transcranial/methods Anemia, sickle cell/diagnosis Anemia, sickle cell/therapy Hemoglobin/sickle Stroke/prevention & control Child Adolescent Guideline BACKGROUND: Sickle cell disease is the most common monogenic hereditary disease in Brazil. Although strokes are one of the main causes of morbidity and mortality in these patients, the use of transcranial Doppler to identify children at risk is not universally used. OBJECTIVE: To develop Brazilian guidelines for the use of transcranial Doppler in sickle cell disease children and adolescents, so that related health policies can be expanded, and thus contribute to reduce morbidity and mortality. METHODS: The guidelines were formulated in a consensus meeting of experts in transcranial Doppler and sickle cell disease. The issues discussed were previously formulated and scientific articles in databases (MEDLINE, SciELO and Cochrane) were carefully analyzed. The consensus for each question was obtained by a vote of experts on the specific theme. RESULTS: Recommendations were made, including indications for the use of transcranial Doppler according to the sickle cell disease genotype and patients age; the necessary conditions to perform the exam and its periodicity depending on exam results; the criteria for the indication of blood transfusions and iron chelation therapy; the indication of hydroxyurea; and the therapeutic approach in cases of conditional transcranial Doppler. CONCLUSION: The Brazilian guidelines on the use of transcranial doppler in sickle cell disease patients may reduce the risk of strokes, and thus reduce the morbidity and mortality and improve the quality of life of sickle cell disease patients.info:eu-repo/semantics/openAccessAssociação Brasileira de Hematologia e Hemoterapia e Terapia CelularRevista Brasileira de Hematologia e Hemoterapia v.33 n.1 20112011-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000100014en10.5581/1516-8484.20110014
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Lobo,Clarisse Lopes de Castro
Cançado,Rodolfo Delfini
Leite,Ana Claudia Celestino Bezerra
Anjos,Ana Claudia Mendonça dos
Pinto,Ana Cristina Silva
Matta,Andre Palma da Cunha
Silva,Célia Maria
Silva,Gisele Sampaio
Friedrisch,João Ricardo
Braga,Josefina Aparecida Pellegrini
Lange,Marcos Christiano
Figueiredo,Maria Stella
Rugani,Marília Álvares
Veloso,Orlando
Moura,Patrícia Gomes
Cortez,Paulo Ivo
Adams,Robert
Gualandro,Sandra Fátima Menosi
Castilho,Shirley Lopes de
Thomé,Ursula
Zetola,Viviane Flumignan
spellingShingle Lobo,Clarisse Lopes de Castro
Cançado,Rodolfo Delfini
Leite,Ana Claudia Celestino Bezerra
Anjos,Ana Claudia Mendonça dos
Pinto,Ana Cristina Silva
Matta,Andre Palma da Cunha
Silva,Célia Maria
Silva,Gisele Sampaio
Friedrisch,João Ricardo
Braga,Josefina Aparecida Pellegrini
Lange,Marcos Christiano
Figueiredo,Maria Stella
Rugani,Marília Álvares
Veloso,Orlando
Moura,Patrícia Gomes
Cortez,Paulo Ivo
Adams,Robert
Gualandro,Sandra Fátima Menosi
Castilho,Shirley Lopes de
Thomé,Ursula
Zetola,Viviane Flumignan
Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease
author_facet Lobo,Clarisse Lopes de Castro
Cançado,Rodolfo Delfini
Leite,Ana Claudia Celestino Bezerra
Anjos,Ana Claudia Mendonça dos
Pinto,Ana Cristina Silva
Matta,Andre Palma da Cunha
Silva,Célia Maria
Silva,Gisele Sampaio
Friedrisch,João Ricardo
Braga,Josefina Aparecida Pellegrini
Lange,Marcos Christiano
Figueiredo,Maria Stella
Rugani,Marília Álvares
Veloso,Orlando
Moura,Patrícia Gomes
Cortez,Paulo Ivo
Adams,Robert
Gualandro,Sandra Fátima Menosi
Castilho,Shirley Lopes de
Thomé,Ursula
Zetola,Viviane Flumignan
author_sort Lobo,Clarisse Lopes de Castro
title Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease
title_short Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease
title_full Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease
title_fullStr Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease
title_full_unstemmed Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease
title_sort brazilian guidelines for transcranial doppler in children and adolescents with sickle cell disease
description BACKGROUND: Sickle cell disease is the most common monogenic hereditary disease in Brazil. Although strokes are one of the main causes of morbidity and mortality in these patients, the use of transcranial Doppler to identify children at risk is not universally used. OBJECTIVE: To develop Brazilian guidelines for the use of transcranial Doppler in sickle cell disease children and adolescents, so that related health policies can be expanded, and thus contribute to reduce morbidity and mortality. METHODS: The guidelines were formulated in a consensus meeting of experts in transcranial Doppler and sickle cell disease. The issues discussed were previously formulated and scientific articles in databases (MEDLINE, SciELO and Cochrane) were carefully analyzed. The consensus for each question was obtained by a vote of experts on the specific theme. RESULTS: Recommendations were made, including indications for the use of transcranial Doppler according to the sickle cell disease genotype and patients age; the necessary conditions to perform the exam and its periodicity depending on exam results; the criteria for the indication of blood transfusions and iron chelation therapy; the indication of hydroxyurea; and the therapeutic approach in cases of conditional transcranial Doppler. CONCLUSION: The Brazilian guidelines on the use of transcranial doppler in sickle cell disease patients may reduce the risk of strokes, and thus reduce the morbidity and mortality and improve the quality of life of sickle cell disease patients.
publisher Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
publishDate 2011
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000100014
work_keys_str_mv AT loboclarisselopesdecastro brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT cancadorodolfodelfini brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT leiteanaclaudiacelestinobezerra brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT anjosanaclaudiamendoncados brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT pintoanacristinasilva brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT mattaandrepalmadacunha brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT silvaceliamaria brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT silvagiselesampaio brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT friedrischjoaoricardo brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT bragajosefinaaparecidapellegrini brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT langemarcoschristiano brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT figueiredomariastella brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT ruganimariliaalvares brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT velosoorlando brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT mourapatriciagomes brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT cortezpauloivo brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT adamsrobert brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT gualandrosandrafatimamenosi brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT castilhoshirleylopesde brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT thomeursula brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
AT zetolavivianeflumignan brazilianguidelinesfortranscranialdopplerinchildrenandadolescentswithsicklecelldisease
_version_ 1756423525301747712